MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model

    J. Follett, J. Fox, E. Gustavsson, M. Farrrer (Vancouver, BC, Canada)

    Objective: To study the effects of DNAJC13 p.Asn855Ser mutant gene dysfunction in a physiological context, and to help define molecular mechanisms for disease, using a…
  • 2019 International Congress

    Therapeutic intervention of LRRK2 kinase inhibitors in Vps35 p.D620N Parkinsonism

    I. Tatarnikov, J. Follett, J. Fox, M. Farrer (Vancouver, BC, Canada)

    Objective: To explore the therapeutic potential of LRRK2 kinase inhibitors in a Vps35 p.D620N mouse model of Parkinsonsim. Background: The discovery of a missense mutation, Vps35 p.D620N…
  • 2019 International Congress

    Evaluation of nigral neuronal apoptosis during postnatal development and adulthood of mice strains with differential sensitivity to MPTP

    Y. H, V. Dj, C. Sagar, R. Tr, P. Alladi (Bangalore, India)

    Objective: Compare nigral neurons in C57BL/6J, CD-1 and their F1 crossbreds with respect to developmental apoptosis in the nigra during postnatal and to assess MPTP-induced…
  • 2019 International Congress

    Extracellular α-synuclein enters dopaminergic neurons by modulating flotillin-1-assisted DAT endocytosis

    T. Hasegawa, J. Kobayashi, N. Sugeno, S. Yoshida, T. Akiyama, Y. Miki, M. Fukuda, M. Ezura, A. Kikuchi, T. Baba, A. Takeda, K. Wakabayashi, H. Okano, M. Aoki (Sendai, Japan)

    Objective: In this study, we examine the regulatory role of flotillin-1 in dopamine transporter (DAT) trafficking and the impact of extracellular α-synuclein (αS) on this…
  • 2019 International Congress

    RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

    K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

    Objective: To investigate the role of RNA binding protein Elavl in Parkinson’s disease related adaptive changes in the striatal transcriptome. Background: Elav-like (Elavl or Hu)…
  • 2019 International Congress

    Lymphocyte Senescence in Parkinson’s Disease

    M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To characterise T- and B-lymphocyte senescence in early stage Parkinson’s disease (PD). Background: Evidence suggests that the immune system may contribute to PD aetiopathogenesis,…
  • 2019 International Congress

    Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias

    X. Jin, D. Milakara, K. Schwabe, J. Krauss, M. Alam (Nanjing, China)

    Objective: This study aimed to investigate the firing properties of fast spiking interneurons (FSIs) and medium spiny neurons (MSNs) of the dorsomedial striatum (DLStr) and…
  • 2019 International Congress

    Local field potential recordings in the human pallidum using externalized directional DBS leads

    L. Johnson, J. Aman, D. Escobar Sanabria, J. Wang, R. Patriat, M. Petrucci, M. Hill, G. Molnar, S. Cooper, L. Schrock, C. Mackinnon, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)

    Objective: To characterize the spatial distribution and spectral profile of local field potential (LFP) activity in the internal segment of the globus pallidus (GPi) in…
  • 2019 International Congress

    The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study

    J. Kauffmann, M. Unger, G. Giebel, D. Grün, K. Faßbender, M. Fousse (Homburg, Germany)

    Objective: To elucidate the role of neuroendocrine hormones in Parkinson’s disease (PD) and evaluate their potential utilization as biomarkers. Background: A growing body of evidence,…
  • 2019 International Congress

    Parkinson’s Disease Correlates with Reduced Risk of Hypertension

    S. Khakimova, KH. Daminova (Tashkent, Uzbekistan)

    Objective: The aim of the present study was to assess the prevalence of hypertension according to the duration of PD.The aim of the present study…
  • « Previous Page
  • 1
  • …
  • 1355
  • 1356
  • 1357
  • 1358
  • 1359
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley